Baxter International | BAX - Ebitda

Stock Price
18.16
Daily Change
-0.25 -1.36%
Monthly
6.07%
Yearly
-39.91%
Q2 Forecast
17.77

Baxter International reported $426M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 19.86M 2.06M Dec/2025
Avanos Medical USD 10M 73.9M Sep/2025
Baxter International USD 426M 36M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.16B 213M Dec/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
Dexcom USD 422.2M 53.8M Dec/2025
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Fresenius EUR 850M 22M Sep/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Halozyme Therapeutics USD 21.9M 226.34M Dec/2025
ICU Medical USD 98.19M 27.67M Dec/2025
Insulet USD 194M 34M Dec/2025
Integra LifeSciences USD 104.21M 25.76M Dec/2025
Intuitive Surgical USD 1.09B 165.5M Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Laboratory Of America USD 588.1M 24.1M Dec/2025
Masimo USD 91.9M 19.9M Sep/2025
Medtronic USD 2.93B 482M Dec/2025
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Smith & Nephew USD 796M 139M Dec/2025
Stryker USD 1.67B 206M Sep/2025
Tandem Diabetes Care USD 32.9M 30.13M Dec/2025
Teleflex USD -328.81M 536.43M Sep/2025
Terumo JPY 69.99B 3.22B Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025